Healthcare Services

Global Nocturia Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

April 3, 2026April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Nocturia Market During 2026–2030?

The nocturia market has experienced robust expansion in recent years. It is projected to increase from $3.1 billion in 2025 to $3.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.0%. The historical growth in this market can be linked to factors like aging population growth, increased incidence of benign prostatic hyperplasia, rising prevalence of urinary tract infections, widespread use of diuretic medications, and limited early diagnostic awareness.

The nocturia market size is anticipated to experience substantial growth over the next few years. Its valuation is projected to reach $4.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. The expansion during the forecast period is driven by factors such as the increasing demand for personalized treatment, the proliferation of home care therapies, escalating healthcare expenditure, a heightened emphasis on sleep quality management, and improved access to urology specialists. Prominent trends throughout the forecast period include a growing geriatric population alongside age-related urological disorders, the increasing prevalence of diabetes and metabolic disorders, greater awareness and diagnosis of lower urinary tract symptoms, a transition toward combination drug therapies, and the broadening of home-based nocturia management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

What Drivers Are Expected To Influence The Nocturia Market During The Forecast Period?

The increasing occurrence of cardiovascular diseases (CVDs) is anticipated to boost the expansion of the nocturia market. These disorders, which affect the heart and blood vessels, including conditions such as heart disease, stroke, and hypertension, are growing in prevalence due to factors like aging populations, sedentary lifestyles, unhealthy diets, smoking, excessive alcohol consumption, obesity, high blood pressure, high cholesterol, diabetes, and genetic predisposition. Patients suffering from cardiovascular diseases frequently experience nocturia as a symptom, thereby generating greater demand for diagnostic and treatment solutions. As the global incidence of cardiovascular conditions continues to climb, influenced by aging demographics and lifestyle choices, the necessity for effective nocturia management will intensify. For instance, in September 2025, the British Heart Foundation, a UK-based charity, reported that across the UK, more than 7.6 million people, specifically over 4 million men and more than 3.6 million women, are living with cardiovascular disease. Furthermore, projections indicate that this number could rise by approximately 1 million by 2030 and by around 2 million by 2040, driven largely by an aging population and improved survival rates. Hence, the rising prevalence of cardiovascular diseases is a significant factor driving the growth of the nocturia market.

How Are The Various Segments Of The Nocturia Market Categorized?

The nocturia market covered in this report is segmented –

1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs

2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria

3) By Causes: Urological Infection, Tumor Of The Bladder, Diuretic Medications, Regular Alcohol Or Coffee, Liver Infection, Diabetes, Pregnancy, Other Causes

4) By End User: Hospitals, Home Care, Clinics

Subsegments:

1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine

2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin

3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin

4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate

5) By Other Drugs: Alpha-Blockers, Beta-3 Agonists

Which Market Trends Are Creating New Opportunities In The Nocturia Market?

Leading companies operating within the nocturia market are concentrating on developing innovative products, such as orally disintegrating tablets, to improve patient convenience and compliance. Orally disintegrating tablets (ODTs) are solid dosage forms that dissolve rapidly in the mouth without needing water, making them suitable for patients who experience difficulty swallowing. For instance, in July 2024, Adalvo Limited, a Malta-based pharmaceutical company, launched Desmopressin ODT in Europe to manage conditions that result in the body losing too much fluid, such as central cranial diabetes insipidus. This synthetic form of vasopressin tablet addresses diabetes insipidus, excessive thirst and urination, and bedwetting by mimicking the natural hormone and reducing the amount of water eliminated in urine. It is also utilized to control bleeding in mild to moderate hemophilia A and von Willebrand disease by encouraging the release of blood clotting factors.

Which Major Firms Influence Developments In The Nocturia Market?

Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

Read the full nocturia market report here:

https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

Which Region Is Forecast To Lead The Nocturia Market In Terms Of Market Size?

North America was the largest region in the nocturia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nocturia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21232&type=smp

Browse Through More Reports Similar to the Global Nocturia Market 2026, By The Business Research Company

Retinal Disorder Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Night Vision Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/night-vision-devices-global-market-report

Optic Nerve Disorders Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795